icon-folder.gif   Conference Reports for NATAP  
 
  13th International Workshop on Clinical Pharmacology of HIV Therapy
Barcelona, Spain
April 16-18, 2012
Back grey_arrow_rt.gif
 
 
 
Antiviral activity, exposure-response, and resistance analyses of monotherapy with the novel HIV nucleoside reverse transcriptase inhibitor (NRTI) BMS-986001 in antiretroviral treatment-experienced subjects
 
 
  Reported by Jules Levin
13th International Workshop on Clinical Pharmacology of HIV Therapy 16-18 April 2012, Barcelona, Spain
 
C Hwang,1 L Zhu,1 HM Chan,1 I Chang,1 GJ Hanna,1 R Bertz,1 D Grasela1 1Bristol-Myers Squibb, Research and Development, Princeton, NJ, USA

PK1.gif

PK2.gif

PK3.gif

PK4.gif

PK5.gif

PK6.gif

PK7.gif

PK8.gif